BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells

BACKGROUND: Efficacy and safety of anticancer drugs are traditionally studied using cancer cell lines and animal models. The thienodiazepine class of BET inhibitors, such as JQ1, has been extensively studied for the potential treatment of hematological malignancies and several small molecules belong...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghamdi, Saeed, Khan, Irfan, Beeravolu, Naimisha, McKee, Christina, Thibodeau, Bryan, Wilson, George, Chaudhry, G. Rasul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736146/
https://www.ncbi.nlm.nih.gov/pubmed/26830473
http://dx.doi.org/10.1186/s13287-016-0278-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736146/
https://www.ncbi.nlm.nih.gov/pubmed/26830473
http://dx.doi.org/10.1186/s13287-016-0278-3

Ejemplares similares